NZ250588A - 2-amino-6,7-dihydroxy-4-thiaheptanoic acid derivatives - Google Patents
2-amino-6,7-dihydroxy-4-thiaheptanoic acid derivativesInfo
- Publication number
- NZ250588A NZ250588A NZ250588A NZ25058893A NZ250588A NZ 250588 A NZ250588 A NZ 250588A NZ 250588 A NZ250588 A NZ 250588A NZ 25058893 A NZ25058893 A NZ 25058893A NZ 250588 A NZ250588 A NZ 250588A
- Authority
- NZ
- New Zealand
- Prior art keywords
- compound
- amino
- gly
- glu
- bis
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
- C07K7/04—Linear peptides containing only normal peptide links
- C07K7/06—Linear peptides containing only normal peptide links having 5 to 11 amino acids
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/08—Tripeptides
- C07K5/0802—Tripeptides with the first amino acid being neutral
- C07K5/0804—Tripeptides with the first amino acid being neutral and aliphatic
- C07K5/0806—Tripeptides with the first amino acid being neutral and aliphatic the side chain containing 0 or 1 carbon atoms, i.e. Gly, Ala
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/06—Dipeptides
- C07K5/06008—Dipeptides with the first amino acid being neutral
- C07K5/06017—Dipeptides with the first amino acid being neutral and aliphatic
- C07K5/06026—Dipeptides with the first amino acid being neutral and aliphatic the side chain containing 0 or 1 carbon atom, i.e. Gly or Ala
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/06—Dipeptides
- C07K5/06008—Dipeptides with the first amino acid being neutral
- C07K5/06017—Dipeptides with the first amino acid being neutral and aliphatic
- C07K5/0606—Dipeptides with the first amino acid being neutral and aliphatic the side chain containing heteroatoms not provided for by C07K5/06086 - C07K5/06139, e.g. Ser, Met, Cys, Thr
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/08—Tripeptides
- C07K5/0802—Tripeptides with the first amino acid being neutral
- C07K5/0804—Tripeptides with the first amino acid being neutral and aliphatic
- C07K5/081—Tripeptides with the first amino acid being neutral and aliphatic the side chain containing O or S as heteroatoms, e.g. Cys, Ser
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/08—Tripeptides
- C07K5/0819—Tripeptides with the first amino acid being acidic
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/10—Tetrapeptides
- C07K5/1002—Tetrapeptides with the first amino acid being neutral
- C07K5/1005—Tetrapeptides with the first amino acid being neutral and aliphatic
- C07K5/1013—Tetrapeptides with the first amino acid being neutral and aliphatic the side chain containing O or S as heteroatoms, e.g. Cys, Ser
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Genetics & Genomics (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- General Health & Medical Sciences (AREA)
- Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP34906292 | 1992-12-28 | ||
| JP5618593 | 1993-03-16 | ||
| JP18173593 | 1993-07-22 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| NZ250588A true NZ250588A (en) | 1995-03-28 |
Family
ID=27295829
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NZ250588A NZ250588A (en) | 1992-12-28 | 1993-12-23 | 2-amino-6,7-dihydroxy-4-thiaheptanoic acid derivatives |
Country Status (15)
| Country | Link |
|---|---|
| US (1) | US5478808A (enExample) |
| EP (1) | EP0604957B1 (enExample) |
| KR (1) | KR940014436A (enExample) |
| CN (1) | CN1094731A (enExample) |
| AT (1) | ATE170871T1 (enExample) |
| AU (1) | AU666789B2 (enExample) |
| CA (1) | CA2112523A1 (enExample) |
| DE (1) | DE69320931T2 (enExample) |
| FI (1) | FI935888A7 (enExample) |
| HU (1) | HUT65865A (enExample) |
| IL (1) | IL108173A (enExample) |
| NO (1) | NO934834L (enExample) |
| NZ (1) | NZ250588A (enExample) |
| PH (1) | PH30687A (enExample) |
| TW (1) | TW264479B (enExample) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6977292B2 (en) * | 2000-09-01 | 2005-12-20 | Gryphon Therapeutics | Nucleophile-stable thioester generating compounds, methods of production and use |
| EP1382352A1 (de) * | 2002-07-19 | 2004-01-21 | GBF Gesellschaft für Biotechnologische Forschung mbH | Bisacyloxypropylcystein-Konjugate und deren Verwendung |
| DE102005024040A1 (de) * | 2005-05-25 | 2006-12-14 | Rovi Gmbh & Co. Kosmetische Rohstoffe Kg | Kosmetisches oder therapeutisches Kombinationspräparat mit Theanin |
| US8008260B2 (en) | 2005-06-13 | 2011-08-30 | Cleveland Clinic Foundation | Methods of protecting against apoptosis using lipopeptides |
| US8299129B2 (en) | 2006-03-01 | 2012-10-30 | Fukuoka Prefectural Government | Peptide lipid-containing carrier and method for introducing compound into cells using same |
| DE102009034779A1 (de) * | 2009-07-25 | 2011-02-03 | Emc Microcollections Gmbh | Synthetische Analoga bakterieller Lipopeptide und ihre Anwendung zur Therapie und Prophylaxe allergischer Erkrankungen |
| EA031379B1 (ru) * | 2010-03-23 | 2018-12-28 | Новартис Аг | Соединения (липопептиды на основе цистеина) и композиции в качестве агонистов tlr2, применяемые для лечения инфекционных, воспалительных, респираторных и других заболеваний |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0000330B1 (de) * | 1977-06-20 | 1981-08-05 | Ciba-Geigy Ag | Lipopeptide, Verfahren zu deren Herstellung und sie enthaltende pharmazeutische Präparate |
| EP0014815A3 (de) * | 1978-12-20 | 1980-10-29 | Ciba-Geigy Ag | Peptidderivate, Verfahren zu deren Herstellung und Zwischenprodukte sowie pharmazeutische Präparate mit einer dieser Verbindungen |
| ATE67769T1 (de) * | 1983-01-25 | 1991-10-15 | Ciba Geigy Ag | Neue peptidderivate. |
| DE3546150A1 (de) * | 1985-06-24 | 1987-01-22 | Hoechst Ag | Membrananker-wirkstoffkonjugat, seine herstellung sowie seine verwendung |
| JPH0446194A (ja) * | 1990-06-13 | 1992-02-17 | Fujisawa Pharmaceut Co Ltd | Ｗｓ１２７９ａ物質、その生産法及び用途 |
| JPH0499796A (ja) * | 1990-08-13 | 1992-03-31 | Kazuo Achinami | 新規リポペプタイド及び抗腫瘍剤 |
| SG47406A1 (en) * | 1991-12-19 | 1998-04-17 | Ciba Geigy Ag | Aminosulfonic acid derivatives and processes for their preparation |
-
1993
- 1993-12-21 AU AU52614/93A patent/AU666789B2/en not_active Ceased
- 1993-12-22 TW TW082110873A patent/TW264479B/zh active
- 1993-12-23 NZ NZ250588A patent/NZ250588A/en unknown
- 1993-12-24 IL IL108173A patent/IL108173A/xx unknown
- 1993-12-27 FI FI935888A patent/FI935888A7/fi not_active Application Discontinuation
- 1993-12-27 PH PH47555A patent/PH30687A/en unknown
- 1993-12-27 AT AT93120970T patent/ATE170871T1/de not_active IP Right Cessation
- 1993-12-27 EP EP93120970A patent/EP0604957B1/en not_active Expired - Lifetime
- 1993-12-27 HU HU9303761A patent/HUT65865A/hu unknown
- 1993-12-27 DE DE69320931T patent/DE69320931T2/de not_active Expired - Fee Related
- 1993-12-27 NO NO934834A patent/NO934834L/no unknown
- 1993-12-28 CN CN93121751A patent/CN1094731A/zh active Pending
- 1993-12-28 US US08/174,374 patent/US5478808A/en not_active Expired - Fee Related
- 1993-12-28 KR KR1019930030357A patent/KR940014436A/ko not_active Withdrawn
- 1993-12-29 CA CA002112523A patent/CA2112523A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| FI935888A0 (fi) | 1993-12-27 |
| IL108173A (en) | 1998-03-10 |
| HU9303761D0 (en) | 1994-04-28 |
| TW264479B (enExample) | 1995-12-01 |
| NO934834L (no) | 1994-06-29 |
| EP0604957B1 (en) | 1998-09-09 |
| DE69320931D1 (de) | 1998-10-15 |
| US5478808A (en) | 1995-12-26 |
| CA2112523A1 (en) | 1994-06-29 |
| ATE170871T1 (de) | 1998-09-15 |
| HUT65865A (en) | 1994-07-28 |
| FI935888L (fi) | 1994-06-29 |
| NO934834D0 (no) | 1993-12-27 |
| AU5261493A (en) | 1994-07-07 |
| PH30687A (en) | 1997-09-16 |
| CN1094731A (zh) | 1994-11-09 |
| KR940014436A (ko) | 1994-07-18 |
| FI935888A7 (fi) | 1994-06-29 |
| EP0604957A1 (en) | 1994-07-06 |
| DE69320931T2 (de) | 1999-05-20 |
| IL108173A0 (en) | 1994-04-12 |
| AU666789B2 (en) | 1996-02-22 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP0114787B1 (de) | Neue Peptidderivate | |
| Atherton et al. | Synthesis and structure-activity relationships of antibacterial phosphonopeptides incorporating (1-aminoethyl) phosphonic acid and (aminomethyl) phosphonic acid | |
| EP0565567B1 (en) | Amides of antibiotic ge 2270 factors | |
| US3778426A (en) | Therapeutically useful polypeptides | |
| EP0111266A2 (de) | Substituierte Tetrapeptide | |
| AU2005245962A1 (en) | Bacterial efflux pump inhibitors and methods of treating bacterial infections | |
| US4816560A (en) | Partially retro-inverted tuftsin analogues, method for the preparation thereof and pharmaceutical compositions containing them | |
| JPH06508126A (ja) | ボンベシン類似体類 | |
| US5478808A (en) | 2-amino-6,7-dihydroxy-4-thiaheptanoic acid derivatives, production and use thereof | |
| US5478809A (en) | TAN-1511, its derivatives, production and use thereof | |
| EP3169698B1 (en) | Novel compounds | |
| JP3556967B2 (ja) | ２−アミノ−６，７−ジヒドロキシ−４−チアヘプタン酸誘導体 | |
| Blagodarov et al. | Improving the synthesis of hemin derivatives and their effect on bacterial biofilms | |
| AU721261B2 (en) | Peptide inhibitors of hematopoietic cell proliferation | |
| JP2008514561A (ja) | 抗菌性アミドマクロサイクルｉｖ | |
| EP0638588A1 (en) | Derivatives of 6,7-Dihydroxy-4-thiaheptonic acid and their use | |
| CA1247084A (en) | Peptide process for preparation thereof and use thereof | |
| PT93380B (pt) | Processo para a preparacao de peptidos sdk | |
| JPH07252295A (ja) | ６，７−ジヒドロキシ−４−チアヘプタン酸誘導体 | |
| JP5097104B2 (ja) | 新規イソジペプチド | |
| JPH07126243A (ja) | チオグリセロール誘導体 | |
| JPH07252163A (ja) | 血小板減少症治療剤 | |
| JPH07145084A (ja) | Ｔａｎ−１５１１関連化合物 | |
| JPH0253800A (ja) | ペプチド及び抗痴呆剤 | |
| IE51684B1 (en) | Peptides,process for their preparation and pharmaceutical compositions containing them |